Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 20/20 | 0.79 |
| ▸ | RAMP1 | O60894 | 8/20 | 0.79 |
| ▸ | CALCA | P06881 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7831849 | 0.95 | CALCRL (0.87) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL7830129 | 0.93 | CALCRL (0.92) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL3957978 | 0.91 | CALCRL (0.66) | CALCRLRAMP1CYP3A4 | |
| SCHEMBL3956962 | 0.90 | CALCRL (0.70) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL3959678 | 0.90 | CALCRL (0.70) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL3961995 | 0.89 | CALCRL (0.64) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL3958399 | 0.88 | CALCRL (1.00) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL3958152 | 0.88 | CALCRL (1.00) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL3961638 | 0.88 | CALCRL (1.00) | CALCRLRAMP1CALCACYP3A4 | |
| SCHEMBL3965896 | 0.88 | CALCRL (1.00) | CALCRLRAMP1CALCACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | RUDOLF KLAUS (DE) | 2001-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010036946-A1 | Modified amino acids, pharmaceuticals containing these compounds and method for their production | PTMS, SRMS, OPRM1 | CALCRL 276/4885RAMP1 434/4885CALCA 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.